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Abstract text.  
Singlet oxygen (
1
O2), as an important kind of reactive oxygen species (ROS) and main therapeutic 
agent in photodynamic therapy (PDT), only have a half-life of 40 ns and an effective radius of 20 nm, 
which cause significant obstacles for improving PDT efficacy. In this work, we developed novel 
upconversion nanoparticle (UCN)-based nanoplatforms with a minimized distance between UCNs and 
a photosensitizer, protoporphyrin IX (PpIX), and a controllable payload of PpIX, to enhance and 
control ROS production. The ability of the nanoplatform to target different subcellular organelles such 
as cell membrane and mitochondria was demonstrated via surface modification of the nanoplatform 
with different targeting ligands. The results showed that the mitochondria-targeting nanoplatforms 
resulted in significantly increased capability of both tumor cell-killing and inhibition of tumor growth. 
Subcellular targeting of nanoparticles leads to the death of cancer cells in different manners. However, 
the efficiency of ROS generation almost had no influence on the tumor cell viability during the period 
of evaluation. These findings suggest that specific subcellular targeting of the nanoplatforms enhances 
the PDT efficacy more effectively than the increase of ROS production, and may shed light on future 
novel designs of effective and controllable PDT nanoplatforms. 
 
1. Introduction 
Photodynamic therapy (PDT) is a tumor-ablative oncologic intervention that involves the excitation of 
photosensitizer (PS) molecules with light of a specific wavelength
[1,2]
 to produce cytotoxic reactive 
oxygen species (ROS) for irreversibly damaging tumor cells
[3]
. Its merits are minimal invasiveness 
and low side effects. However, the challenges are to ablate tumor tissues with high efficiency, 
including limited penetrating depths, low ROS production efficiency, short half-lives and effective 
radii of singlet oxygen (
1
O2), the most effective kind of ROS
[4,5]
. As an emerging platform in the field 
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of PDT, upconversion nanoparticles (UCNs) serving as a PS carrier have attracted intensive attention 
in recent years
[6,7]
. Upon near-infrared (NIR) light excitation, UCNs are able to emit visible or 
ultraviolet light with controllable wavelengths, which could match the absorption wavelength of the 
loaded photosensitizer, and therefore play as a transducer. Given the deep tissue penetration capability 
of NIR light
[8]
, NIR-excited UCNs can be located in in-depth tissues to activate loaded PS molecules 
for PDT treatment.  
 
In the past decade, various strategies to load PS molecules onto UCNs have been designed for 
improving PDT efficacy,
 
mainly in terms of optimization of ROS production
[9-16]
. One of the 
strategies was to improve the match between the wavelength bands of UCN emission and PS 
absorption. For example, Chen et. al.
[9]
 chose methylene blue as the photosensitizer which had a 
mismatch of <5 nm between its absorption wavelength and the emission wavelength of UCNs. Idris 
et. al.
[10]
 simultaneously conjugated a type of UCNs with two different PS molecules, in which the 
absorption peak of each PS molecule matched well with one of the major emission peaks of UCNs for 
efficient energy transfer and absorption. However, these optimized methods were still not sufficient to 
regress tumor cells completely
[10]
. Other strategies were also designed to elevate the loading capacity 
of the photosensitizer in order to increase ROS production. For example, Cui et al.
[11]
 developed 
amphiphilic chitosan modified UCNs with a PS loading capacity of up to ~10%, resulting in 
inhibiting 66 wt% tumor growth as compared to the blank control. However, in these approaches, a 
coating layer of silica or polymer with a thickness generally greater than 10 nm
[9-15]
 was demanded for 
sufficient PS loading.  Owing to the fact that ROS production is an energy transfer process, a thicker 
layer of PS loading, which means the increased distance between PS molecules and UCNs, will 
largely reduce the efficiency of energy transfer. Furthermore, the increased production of ROS arising 
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from the increasing concentration of nanocarriers
[14,16]
 may also lead to the risks of toxicity. Thus, it is 
worth developing novel strategies to improve the extent of tumor regression via the increase of PDT 
efficacy.  
 
Because of the short half-life and effective radius of 
1
O2, the dominant kind of ROS
[5,17]
, the effective 
area to damage tumor cells is limited to the neighborhood of the nanoplatforms in subcellular scale. 
Meanwhile, each therapeutic agent has an optimal mechanism of action, which usually occurs 
primarily in a specific subcellular organelle in order to initiate precise inhibition or apoptosis of a 
cancer cell
[18-20]
. For example, pro-apoptotic drugs have primary effect on mitochondrial 
membrane
[21]
, and oligonucleotides for gene therapy must home in the cytosol and nucleus
[22,23]
. 
Previous results from the delivery of classical drugs to specific organelles revealed that the 
therapeutic efficacy was several-fold greater than that of non-targeted drugs through modification 
with liposome
[24]
, dendrimer
[25]
,
 
or polymeric carriers
[26-29]
; those non-targeted drugs were 
uncontrolledly released under the disintegration of liposomes or the degradation of polymeric carriers. 
Therefore, it is reasonable to hypothesize that UCN-based PDT nanoplatforms targeting to particular 
subcellular organelles can precisely generate 
1
O2 within the effective location to kill tumor cells, and 
can be spatiotemporally controllable since the NIR light can trigger 
1
O2 generation in an immediate 
and sensitive manner
[30-32]
.   
 
Furthermore, direct experimental results concerning the dose effect of ROS on PDT efficacy have not 
been reported in the literature despite that ROS is the therapeutic agent in photodynamic therapy. 
Photosensitizers can continuously produce ROS so long as it is under the illumination of an 
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appropriate light with a continuous oxygen supply
[30, 32-34]
,
 
meaning that a sufficient amount of ROS 
can be generated even by a nanocarrier with a low loading of a photosensitizer under a prolonged 
illumination. Yet, it remains unclear whether the amount of ROS produced under a relatively long 
irradiation time is sufficient for efficient PDT therapy.  
 
To address the above issues, we aimed to identify the crucial factors that can improve the PDT 
efficacy effectively by increasing ROS production and targeting ROS production at the subcellular 
position. Nanoplatforms, based on UCN as a light transducer and protoporphyrin IX (PpIX) as the ROS 
producer, with novel features were designed.  To investigate the effect of ROS production on PDT 
efficacy, 1) a thinner PpIX-loaded layer (3~5 nm) outside UCN nanoparticles was designed to improve 
the efficiency of energy transfer between UCN core and PpIX molecules; and 2) a controllable 
payload of PpIX was applied to adjust the efficiency of ROS generation. To study the impact of 
subcellular positioning on PDT efficacy, different pertinent targeting ligands were covalently bonded 
onto the nanoplatform to target different subcellular organelles. The PDT efficacy of novel 
nanoplatforms were characterized through both in vitro and in vivo studies. The effect of irradiation 
time on the PDT therapy was also investigated. 
 
2. Results 
2.1. UCN based PDT nanoplatforms with a 3-5 nm silica coating layer 
Two approaches for loading PpIX in a 3~5 nm silica layer were conducted in this work, together with 
a control method that produced a ~15 nm coating. The thin silica outside nanoparticles, as a close 
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UCN-PpIX proximity for energy transfer, was successfully prepared by a modified reverse 
microemulsion approach[16,34], as shown in Figure 1. Notable features of the modified method 
include: firstly, the addition of a small amount of dimethyl sulfoxide (DMSO) into the water phase of 
the emulsion, which increases the solubility of PpIX in the water phase and therefore improves its 
dispersion; secondly, an aminopropyltriethoxysilane agent was used as a silica precursor for making 
the thin coating layer (denoted as sample APTS). Meanwhile a novel synthetic method was also 
designed in which PpIX was first covalently conjugated with aminopropyltriethoxysilane (see 
Supporting information) [35]. The conjugation was then used as a coating precursor. The latter 
method allowed us to adjust the loading amount of PpIX and the resultant nanoplatforms were 
labeled as sample CovX (X = 1, 1.5, 3, 6, each number indicative of a different amount of PpIX 
feeding, see Figure 1). We also prepared the control samples by coating UCNs with 
tetraethylorthosilicate as a silica precursor (denoted as sample TEOS). TEM images of silica coated 
UCNs are shown in Figure 1. UCNs show monodispersion with a size of ~40 nm in diameter before 
coating. Using aminopropyltriethoxysilane as the precursor successfully limited the thickness of the 
outer coating layer to ~3.0 nm. Similarly, a coating layer by use of silane covalently bonded with PpIX 
has only about 3~5 nm in thickness.  However, coating of a tetraethylorthosilicate-based layer led to 
a ~15 nm increase in thickness of the outer layer.  
 
2.2. Controlled and increased ROS producing efficacy 
The amount of PpIX incorporated in the coating layer was determined by comparing UV–Vis 
absorption measured at 410 nm to a standard concentration-absorption curve. A blank sample of only 
silica coated UCNs was regarded as a control without any absorption at 410 nm in the UV-Vis curve. 
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This indicates that addition of silica has no interference on the UV–Vis absorption of UCNs. The 
results are shown in the table of Figure 1. Under the same amount of PpIX added, use of 
aminopropyltriethoxysilane led to ~1.12% PpIX incorporated in the coating layer, lower than the 
tetraethylorthosilicate of ~1.70%. In contrast, with PpIX pre-attached to aminopropyltriethoxysilane 
as precursor, the loading amounts of PpIX incorporated in the coating layer vary significantly from 
~0.46% (Cov1) to ~3.26% (Cov6). Since the feeding doses of PpIX in samples TEOS and APTS are 
the same as that of Cov6, it can be concluded that the PpIX-silane precursor for sample Cov6 results 
in an enhanced loading amount of PS molecules (~3.26%) compared to those of TEOS (~1.70%) and 
APTS (~1.12%). 
 
The influence of coating layer thickness on the steady state energy transfer efficiency between UCNs 
and PpIX was evaluated by measuring the fluorescent intensity of drug-loaded UCNs
[36]
.
 
As shown in 
the table of Figure 1, all ‘Cov’ samples have the energy transfer efficiency in the range of 32~85% 
with an outer layer of 3~5 nm in thickness. In contrast, sample TEOS with a 15 nm-thick outer layer 
has drastically lower energy transfer efficiency, 13.6%, despite of a higher amount of PpIX 
incorporated in the coating layer than Cov1 and Cov 1.5. Meanwhile, the transient state energy 
transfer efficiency was measured by the luminescence decay lifetime
[36]
. The results showed that the 
decay time of 540 nm emission of UCNs coating with a 3-5nm SiO2 was significantly shortened after 
loading with PpIX, while that of 660nm almost kept the same (shown in Figure S3). Accordingly, the 
energy transfer efficiency was about 42.9%, 41.1%, and 13.6% for the sample Cov3, APTS, and 
TEOS, respectively.  
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The capability of the nanoplatforms to generate ROS was investigated by using a chemical method 
with 1,3-diphenylisobenzofuran (DPBF) as an acceptor of ROS generated. In this assay, the reaction 
of DPBF with ROS results in the decay of its absorption intensity of DPBF in UV-Vis curve. Such a 
spectral change of DPBF in UV-Vis curve allows us to determine the concentration of ROS produced 
from different UCN hybrid samples
[37]
. Under 980 nm laser irradiation, the absorption intensity of 
DPBF at about 400 nm decreased gradually with time in all samples (as shown in Figure S4), from 
which time-dependent curves of ROS generation can be determined. As shown in Figure 2a, under 
the same NIR laser excitation, sample Cov6 possesses the highest ROS generation efficiency, 
followed by samples Cov3, APTS, Cov1.5, consequently, and samples Cov1 and TEOS show the 
lowest. Obviously, with a coating layer of the same thickness of 3~5 nm, the higher the loading 
amount of PpIX incorporated in the coating layer is, the higher the ROS generation efficiency will be. 
Based on the results of samples APTS and Cov3 with almost the same amount of PpIX, the ROS 
generation efficiency is barely influenced by the covalent bonding between PpIX and 
aminopropyltriethoxysilane. However, the ROS generation efficiency of sample Cov3 with the 
thickness of 3~5 nm is much higher than sample TEOS with the coating thickness of ~15 nm, 
although the loading of PpIX on Cov3 is slightly less than TEOS. This observation clearly suggests 
that PpIX loading in the thinner coating layer leads to higher ROS generating efficiency due to a 
shorter distance between photosensitizer molecules and UCNs.  
 
As 
1
O2 is the main executive part with short half-life in ROS, we further determining the generation of 
1
O2 by using 9,10-anthracenediyl-bis(methylene) dimalonic acid (ABMDMA) as the indicator, owing 
to that the absorbance of ABMDMA in visible range can be decayed by 
1
O2
[38,39]
. We found that the 
UV-Vis spectra of samples were gradually quenched with prolonging irradiation time, as shown in 
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Figure S5. Meanwhile the dose of produced 
1
O2 (Figure 2b) showed a similar regularity with the 
results of ROS generation. The results demonstrated the effective production of 
1
O2 by the presented 
nanoplatforms, and the dose of 
1
O2 could be varied with controlling the thickness of coating layer and 
loading amount of PS.  
  
2.3. Subcellular targeting via surface modification 
Due to the availability of the amine group originated from aminopropyltriethoxysilane, a NH2/COOH 
coupling reaction can be used to conjugate certain targeting ligands onto the nanoplatforms. In our 
case, folic acid (FA)
 [37,40]
 and (3-carboxypropyl) triphenylphosphonium bromide (TPP)
 [41,42]
 were 
conjugated onto the surface of nanoparticles respectively (as shown in Figure 3a).  The cellular 
uptake of surface modified UCNs-PpIX nanoparticles was observed using a two-photon fluorescence 
confocal microscope, which is equipped with a 980 nm pulse laser resource. Figure 3a shows images 
of HeLa cells associated with each of these UCNs-PpIX nanoparticles in which nuclei are detected by 
4',6-diamidino-2-phenylindole (DAPI) staining. Each of the UCN-PpIX nanoparticles, stained with 
DAPI, shows green luminescence at the location close to a cell nucleus.  Compared to unmodified 
UCN-PpIX nanoparticles, the modification with FA or TPP significantly increased the cellular uptake 
amount of UCNs. For quantitative analysis, the amounts of UCN-PpIX nanoparticles were determined 
by using inductively coupled plasma-atomic emission spectroscopy (ICP-AES) as summarized in 
Figure 3b. The results showed the surface modification with either FA or TPP ligand increased the 
cellular uptake amount of UCNs-PpIX nanoparticles by up to ~6 times higher than unmodified UCNs-
PpIX nanoparticles, confirming the cell imaging results. Without surface modification, the difference 
in cellular uptake was ~2.5-fold between APTS and Cov6. However, samples APTS and Cov6 with 
FA or TPP modification have similar amounts of cellular uptake. Transmission electron microscopy 
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(TEM) was employed to observe the subcellular locations of the above nanoparticles. Figure 4 shows 
TEM images of HeLa cells incubated with Cov6 samples with different surface modifications. It is 
clearly visible that most of the UCNs-PpIX nanoparticles modified with FA are located near the cell 
membrane. In contrast, the UCNs-PpIX nanoparticles modified with TPP were mainly found near 
mitochondria. 
To further identify mitochondria targeting of TPP modified nanoparticles, Rhodamine 123 (Rh123) 
was used to specifically stain the mitochondria of Hela cells internalized with Cov6-TPP and Cov6-
FA, respectively, while a control experiment without nanoparticles was performed. The images of 
control group indicated the successful staining of DAPI and Rh123 (as shown in Figure 5). For the 
experimental groups, we directly observed the fluorescence of PpIX (ex=552nm, ex=700nm) loaded 
on UCNs. The results showed that for the sample Cov6-FA, the fluorescence from PpIX and Rh123 
are almost separated. In contrast, the fluorescence from PpIX in sample Cov6-TPP are almost covered 
by Rh123, indicating a efficient delivery to mitochondria. For statistically analysizing the targeting 
efficiency, a Pearson’s correlation coefficient that identify colocalization of the fluorescence from 
Rh123 and PpIX was calculated with an imaging analysis software ImageJ

, based on about 2000 
cells for each sample. Pearson’s correlation coefficient is one of the standard procedures in pattern 
recognition for matching one image with another and can be used to describe the degree of overlap 
between two patterns.
[43]
 Our result showed that Pearson Coefficient for the sample Cov6-TPP is 
0.817±0.029, while for the sample Cov6-FA it is 0.567±0.064, which indicates that the modification 
of TPP tailors more nanoparticles to the sites near mitochondria.  
2.4. In vitro studies on the influence of ROS generation, irradiation time and nanoparticle position 
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To study the influence of nanoparticle position on PDT efficacy, we first evaluated all the unmodified 
samples in a control experiment. Without 980 nm irradiation, HeLa cells incubated with all the 
unmodified samples were alive and their viability generally remained almost 100% (Figure 6, blue 
bars). Upon irradiation for 15 min (Figure 6, pink bars), the viability of HeLa cells incubated with all 
the unmodified samples decreased to the range of 60–70%, which implies death of some HeLa cells. 
Although the difference in the cellular uptake between unmodified APTS and unmodified Cov6 was 
~2.5 times, there was almost no significant difference between cell viabilities of both samples. This 
enlightens that the uptake amount of nanoparticles is not the only factor influencing the viability of 
HeLa cells. Furthermore, we performed the same evaluation experiment of cell viability without 
washing after incubation with all the unmodified samples to maintain the same total amounts of 
nanoparticles. Under the same condition of irradiation for 15 min, the average cell viabilities for all 
the unwashed samples were only slightly further decreased (Figure 6, green bars).  Again, this 
implies that cell-killing efficacy is more relevant to the subcellular location of nanoparticles rather 
than the total dose. 
 
The effect of the subcellular locations of UCNs-PpIX nanoparticles on the cell viability was measured 
by Cov6 samples with and without ligand modification. As shown in Figure 7, without NIR 
irradiation, there is no apparent decrease in cell viabilities and no difference for all samples. After 
NIR irradiation for 10 min, the cell viability of HeLa cells incubated with FA-modified Cov6 (located 
near cell membrane) is ~15% lower than treated with unmodified Cov6 (67%~70%). Furthermore, 
cell viability of HeLa cells incubated with TPP-modified Cov6 (located near mitochondria) 
significantly decreased to ~40%, much lower than the sample FA-modified Cov6. As discussed 
earlier, the cellular uptake amount of Cov6-TPP is only slightly lower than that of Cov6-FA (Figure 
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3b). Therefore, these results imply that locating UCNs-PpIX nanoparticles at certain subcellular 
position, such as mitochondria, is more effective for improving PDT efficacy.  
Figure 7 also showed that the effect of irradiation time on the cell viability of each Cov6 sample. The 
results showed that irradiation within 30 min leads to almost the same viability of cells for all 
samples. However, prolongation of exposure time above 30 min results in a further decrease in the 
viability of HeLa cells for all the three kinds of surface modified samples. With the same FA 
modification shown in Figure 8, the cell viabilities of samples APTS, Cov1.5 and Cov6 experienced 
almost the same decreases during the same periods of NIR irradiation. Samples APTS and Cov6 
modified with different ligands were also compared (Figure 9). The results showed no significant 
statistical difference between APTS and Cov6 under the same NIR irradiation time. As shown in 
Figure 2, the ROS generation of Cov6 is about 3-fold higher than samples APTS and Cov1.5. 
Therefore, the above results indicate that there is no direct correlation between the cell viability and 
the amount of ROS generation. 
 
Fluorescence-activated cell sorting (FACS) technique allows us to investigate the mechanisms 
underlying the cytotoxicity of nanoparticles such as the extent of DNA damage
[44]
. The FACS results 
for both two Cov6 samples (Figure 10) showed that the number of cells positively stained by 
Annexin V and/or propidium iodine (PI) increased after 15 min irradiation, demonstrating the death of 
cells. When the irradiation time was prolonged to 60 min, treatment with FA-modified Cov6 led to the 
significant increase of cells only positively stained by PI, indicating that the membrane integrity of 
cells was destroyed in this case. In contrast, TPP-modified Cov6 sample significantly results in the 
location of both Annexin V and PI double stained, indicating the necrosis and late stage apoptosis of 
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HeLa cells with an integrated membrane.  All these experimental results were consistently 
reproducible. 
 
2.5. In vivo studies on the influence of nanoparticle position 
The PDT efficacy of nanoparticles with different surface modifications was further investigated on 
tumor-bearing mouse model with n=6 for each group. For the groups with injected UCNs-PpIX 
nanoparticles under irradiation of NIR laser, green light emitted from in vivo nanoparticles can be 
clearly observed by naked eyes (Figure 11a), indicating the successful NIR penetration through living 
body for its potential in simultaneous NIR fluorescent imaging and PDT. As shown in Figure 11 (b 
and c), the tumors in the two control groups without UCNs-PpIX nanoparticles kept on growing to a 
~2.6-fold volume in 11 days, indicating that NIR light alone has no effect on the growth of the tumor 
tissue. On the contrary, NIR irradiation together with injection of Cov6-FA and Cov6-TPP 
significantly inhibited the tumor growth in spite of the irradiation only performed for an hour in the 
first 2 days. Especially, Cov6-TPP nanoparticles under NIR irradiation show stronger ability of 
inhibiting tumor growth than that of Cov6-FA during the whole period of in vivo experiment. This 
result clearly suggests that TPP modified nanoparticles near mitochondria exert much higher PDT 
efficacy than FA modified ones near cell membrane.    
 
The histological results from tumor-bearing mouse model were shown in Figure 12. The morphology, 
size and staining of the tumor cells in control groups (whether with or without laser irradiation) are at 
variance, indicating the continuous growth of tumor cells without nanoparticles. Meanwhile, after 
injection of nanoparticles, the tumor still kept growing without NIR irradiation. In contrast, markedly 
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increased death of cells was observed after irradiation, as obvious blank or unstained areas can be 
observed. Interestingly, green fluorescence emitted from Cov6-TPP groups (with or without laser) 12 
days after injection, and the illuminating positions overlay the areas of apoptotic/necrotic tumor cells. 
On the contrary, the fluorescence of UCNs cannot be observed for the cell membrane targeted Cov6-
FA sample, which may suggest that the membrane-targeting mode easily results in the metabolism. 
This result indicated that the nanoparticles with the mitochondria targeting behavior could also 
applicable for both long-term therapy and long-term fluorescent imaging.  
 
3. Discussion 
This work modified a classical synthetic process to coat the outer layer of silica by using 
aminopropyltriethoxysilane (or PpIX conjugated aminopropyltriethoxysilane) as a precursor, and the 
thickness of the coating layer can be restricted in ~3 nm. As we know, the efficiency of ROS 
production is based on the energy transfer between UCNs as a donor and PS molecules as an acceptor 
which is inversely proportional to the sixth power of the distance between the donor and acceptor 
pair
[45,46]
.
 
Therefore, the thickness of the coating layer outside UCNs is significantly related to the 
ROS generation efficiency. Our results showed that, compared to sample TEOS with a coating layer 
of ~15 nm in thickness, which is comparable to the references
[9-16]
, all the samples with a coating layer 
of ~3 nm in thickness had much higher energy transfer efficiency between PpIX and UCNs for 
enhancing ROS generation efficiency. Meanwhile the covalent bond between PpIX and 
aminopropyltriethoxysilane enables the control of the amount of PpIX loading within the thin silica 
layer, which resulted in the controllability of ROS production.  
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Another advance for current coating protocol is that the -NH2 from aminopropyltriethoxysilane 
presented on the surface provide further surface modification capabilities for subcellular localization.  
FA is one of the well-established ligands for targeting certain types of cancer cell including HeLa 
cells in current work because folate receptors in such cells are significantly upregulated compared to 
normal healthy cells
[37, 40]
. In this paper, FA-modified UCNs-PpIX nanoparticles are mostly located 
near the cellular membrane instead of lysosome or endosome shown in the literature
[37,40]
. This is 
possibly owing to the multivalent FA receptor association of FA-modified UCNs-PpIX nanoparticles 
and HeLa cells to undergo cellular internalization via endocytosis, which is consistent with the notion 
that high binding avidity can slow down the penetration of nanocarriers due to a ‘binding-site 
barrier’[47]. Meanwhile, TPP is a lipophilic molecule with a cationic phosphonium head, which has 
been demonstrated for mitochondria-targeting delivery of drug payloads. This paper describes for the 
first time conjugating TPP on the surface of UCNs-PpIX nanoparticles rending the nanoparticles with 
the ability to target the mitochondria of HeLa cells, which may be attributed to the substantial 
negative membrane potential at the mitochondrial inner membrane
[41,42]
.  
 
Although various approaches to improve ROS generation have been designed, unclear mechanism 
still remains in the effectiveness of ROS generation on PDT treatment.
 [6-16,30-34,48,49]   
Some 
studies
[14,16,47-50]
 reported the relationship between the concentration of nanoparticles or PS and PDT 
efficacy, but the concentration of nanoparticles or PS is not directly related to the rate or amount of 
ROS generation. Based on our nanoplatforms, it was possible to study whether the amount of ROS 
generated affects the capability of killing cancer cells, which has not been reported before. As shown 
in Figure 8 and Figure 9, we first demonstrated that the dose of ROS does not significantly affect the 
PDT efficacy, at least in the range investigated in this paper. Since it is difficult to quantitate the 
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amount of nanoplatforms at each specific site, the relationship between the ROS generation and PDT 
efficacy still needs further investigation based on the quantitative data of local ROS generation. 
 
The influence of ROS generating time on PDT efficacy is of great importance, because the half-life of 
1
O2 is as short as 40 ns, during which the amount of ROS generation may not be sufficient to damage 
the tumor cells.  In our experiments, we found that a 10 min NIR irradiation leads to a certain 
decrease of cell viability and a prolonged irradiation to more than 30 min results in a further decrease. 
Our FACS result showed that both mitochondria targeting and cell membrane location show a similar 
cell death mechanism within 15 min irradiation, but it shows a position-dependent phenomenon when 
further irradiated for 60 min. This result may be explained by the hypothesis of Nel et. al.
 [51]
 on the 
mechanism of hierarchical oxidative stress: the lowest level of oxidative stress is associated with the 
induction of antioxidant and detoxification defense, but at higher levels of oxidative stress, this 
protective response is overtaken by inflammation and death. The results also showed that after 
extending irradiation time to 60 min, direct destroy of cell membrane is the main death mechanism for 
locating nanoparticles on cell membrane, and necrosis or late-stage apoptosis with keeping membrane 
integrity is dominant for targeting nanoparticles to mitochondria, which indicates that extending ROS 
generation time leads to different cell responses changing from antioxidant defense to different types 
of cell death. Contrary to keeping cells integrity, the cell rupture can spread throughout the body for a 
long time
[52]
, and despite of the unclear effect
[5]
, the segments may cause reactions in normal tissues 
leading to inflammation and edema
[53]
.  
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In vitro and in vivo studies of the effect of the location of nanoplatform on the PDT efficacy was first 
performed in this study. Our results showed that the average cell viabilities under the same 
condition of irradiation for all unmodified UCNs-PpIX nanoparticles (shown in Figure 6) were at 
almost the same level. Meanwhile with or without a washing process, the average cell viabilities 
under the same condition of irradiation were also at the same level with a very slight decrease. This 
implies that the ROS generation outside the HeLa cells does not obviously affect the photodynamic 
efficacy. Previous reports[17,54,55] also indicated that neat PS outside cells possessed extremely low 
PDT efficacy despite their capability for high photochemical yield of ROS.  Thus, it indicates that ROS 
localization inside cells is more important than outside. Furthermore, our experimental results first 
indicate that the viability of HeLa cells treated with FA-modified UCNs-PpIX nanoparticles had a 
much higher decrease, ~15%, than those treated with unmodified UCNs-PpIX nanoparticles, and that 
the HeLa cell viability treated by mitochondria-targeting TPP-modified UCNs-PpIX nanoparticles 
decreased to ~40%. Previous researches[54,55] suggested that mitochondrion is the more potent site 
for PDT than other subcellular sites such as lysosome for cytotoxic activity to living cells. However, 
those experiments employed different PSs for different locations, so it was difficult to determine the 
most influential factors of the PDT efficacy: subcellular location, concentration and/or some intrinsic 
properties. This work was designed to incorporate one sensitizer PpIX for comparison of the 
influence of cellular location of the nanoplatform on PDT efficacy with a similar amount of cellular 
uptake, and therefore provides direct evidence that the more efficient approach for increasing PDT 
efficacy is to tailor the nanoplatform to target certain subcellular sites such as mitochondria. 
 
4. Conclusion 
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With the minimization of the external layer thickness and the increase of the loading capacity of PpIX 
outside a UCN core, the ROS generation rate can be adjusted and controllable. Meanwhile through 
modifying their surface by targeting ligands of FA and TPP, the UCNs-PpIX nanoparticles can target 
the cell membrane and mitochondria of HeLa cells, respectively. Based on these newly designed 
nanoplatforms, we found that the mitochondria targeting mode is more significant for the PDT 
performance of both cell killing (in vitro) and tumor growth inhibition (in vivo) than the cell 
membrane mode. The HeLa cells incubated with UCNs-PpIX nanoparticles showed different death 
mechanisms after 60 min laser exposure: membrane segmentation for membrane targeting, and 
necrosis or late-stage apoptosis for mitochondria targeting. Moreover, the subcellular position near 
mitochondria is much more efficient and effective for higher PDT efficacy than increasing ROS 
generating amount. In summary, we developed novel UCNs-PpIX nanoparticles, which can not only 
control and optimize ROS generation but also target subcellular-scale organelles. The findings 
provide evidence that specific subcellular targeting strategy may be of more importance for 
optimizing PDT efficacy than elevating the dose of ROS. 
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Figure 1. Schematic illustration of modified microemulsion approaches for coating silica and PS on 
upconversion nanoparticles. The inset table shows the feeding and loading amounts of PpIX 
molecules for each sample and their energy transfer efficiency calculated from fluorescent intensity.  
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Figure 2. (a) The ROS generation of different samples as indicated by the decay of absorbance of 
DPBF at 410 nm, and (b) the 1O2 generation of different samples as indicated by the decay of 
absorbance of ABMDMA 
  
     (a)                                                                    (b) 
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Figure 3. Right Panel: Schematic illustration of UCNs-PpIX nanoparticles surface modification with 
folic acid (FA) and (3-carboxypropyl)triphenylphosphonium bromide (TPP), respectively. Two-photon 
confocal fluorescent microscopic images of HeLa cells incubated with different surface modified 
Cov6 samples. Each series can be classified into the nuclei of cells (being dyed in blue by DAPI for 
visualization), PpIX-loaded upconversion nanoparticles, and a combination of both channels, 
respectively. The light source was a 980 nm pulse laser. Left panel: Cellular uptake of different 
surface modified nanoparticles. 
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Figure 4. TEM images of HeLa cells incubated with different surface modified Cov6 samples, 
showing different targeting positions: Unmodified, FA modified and TPP modified sample Cov6 for 
untargeted, membrane targeted and near mitochondria location, respectively.  Arrows point to the 
aggregation of ROS generation nanoplatforms. 
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Figure 5. Multichannel confocal fluorescence micrographs. Blue channel (ex=385 nm, em=470 nm) 
for DAPI stained nuclei. Red channel (ex=552 nm, em=660 nm) for PpIX. Green channel (ex=488 nm, 
em=530 nm) for Rh123 stained mitochondria. 
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Figure 6. The viability of HeLa cells incubated with unmodified samples in dark, or under 980 nm 
irradiation with/without washing off the UCNs-PpIX nanoparticles outside cells.  
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Figure 7. The viability of HeLa cells incubated with different surface modified Cov6 samples after 
irradiation for various periods of time with a 980 nm NIR laser.  
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Figure 8. Cytotoxicity of cells incubated with FA-modified samples exposing to 0~60 min NIR 
irradiation. 
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Figure 9. The viability of HeLa cells incubated with samples APTS and Cov6 with different surface 
modifications in dark, and under 15 min and 40 min irradiations, respectively. 
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Figure 10. Fluorescein annexin-V-FITC/PI double labeling flow cytometry results for HeLa cells 
incubated with samples Cov6-FA and Cov6-TPP in dark and under 15 min and 60 min irradiations, 
respectively.  
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Figure 11. (a) The photograph of the tumor in a mouse exposed to 980 nm laser, showing the 
upconversion fluorescence of UCNs-PpIX nanoparticles; (b) the evolution of tumor size under 
different treatments, in which the red arrow shows that the laser irradiation was implemented on 
the first and second day for 30 min in each day; (c) The photograph of the tumor size evolution from 
day 0 to day 12. Scale bar is 1 cm. 
     
(a)                                                       (b) 
 
(c) 
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Figure 12. Hematoxylin & Eosin (H&E) stained tumor tissues harvested from the mice with different 
treatments after 12 days. The 3
rd
 and 5
th
 Columns are the fluorescent microscopic observation of the 
corresponding samples of the 2
nd
 and 4
th
 Columns, respectively. 
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Novel nanoplatforms for photodynamic therapy (PDT) were developed, featuring with a thin 
coating layer minimizing energy transfer distance, controllable photosensitizer payload, and 
capability of surface modification for organelle targeting. Targeting the reactive oxygen species 
(ROS)-producing nanoplatform to mitochondria was found more effective than optimizing ROS 
production for improving PDT efficacy. The findings may provide a novel strategy for designing 
nanomedicine for PDT.  
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